Literature DB >> 16229217

Tuberculosis epidemiology in India: a review.

V K Chadha1.   

Abstract

High prevalence and incidence of disease and a high rate of transmission of infection characterise the tuberculosis (TB) situation in India. Disease surveys conducted in different parts of the country since the 1950s have reported prevalences of smear-positive pulmonary TB (PTB) of 0.6-7.6 per 1000 population, culture-positive TB of 1.7-9.8 and culture and/or smear-positive TB of 1.8-12.7. The incidence of smear-positive PTB has been observed in the range of 1.0-1.6/1000 and that of culture-positive PTB 1.0-2.5/1000 in the limited number of studies carried out. The annual risk of tuberculous infection (ARTI) had been estimated at 1-2% for most of the tuberculin surveys carried out in different areas over different time periods. During a nationwide study in 2000-2003, the average ARTI in the country was estimated at 1.5%. An increasing trend has been observed in human immunodeficiency virus (HIV) seropositivity among TB cases, which has been found to vary between 0.4% and 28.8% in different studies conducted mostly at tertiary health care centres. The proportion of new cases with multidrug resistance (MDR) was relatively low, at 0.5-5.3%. However, the proportion of MDR cases among previously treated cases varied between 8% and 67%.

Entities:  

Mesh:

Year:  2005        PMID: 16229217

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  23 in total

1.  Nucleotide polymorphism associated with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis.

Authors:  S Srivastava; A Garg; A Ayyagari; K K Nyati; T N Dhole; S K Dwivedi
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

2.  Routine diagnosis of intestinal tuberculosis and Crohn's disease in Southern India.

Authors:  Geir Larsson; Thrivikrama Shenoy; Ramalingom Ramasubramanian; Leena Kondarappassery Balakumaran; Milada Cvancarova Småstuen; Gunnar Aksel Bjune; Bjørn Allan Moum
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

3.  Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic.

Authors:  Kshaunish Das; Uday C Ghoshal; Gopal K Dhali; Jaya Benjamin; Vineet Ahuja; Govind K Makharia
Journal:  Dig Dis Sci       Date:  2008-09-04       Impact factor: 3.199

4.  Tuberculosis and HIV: a global menace exacerbated via sex trafficking.

Authors:  Ashwin S Dharmadhikari; Jhumka Gupta; Michele R Decker; Anita Raj; Jay G Silverman
Journal:  Int J Infect Dis       Date:  2009-01-18       Impact factor: 3.623

Review 5.  Co-infection with human immunodeficiency virus and tuberculosis in Asia.

Authors:  Sten H Vermund; Naoki Yamamoto
Journal:  Tuberculosis (Edinb)       Date:  2007-07-16       Impact factor: 3.131

Review 6.  Infectious uveitis: an Asian perspective.

Authors:  Aniruddha Agarwal; Kanika Aggarwal; Vishali Gupta
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

7.  Management of tuberculosis: From drug treatment to control program.

Authors:  Gopi C Khilnani; Neetu Jain
Journal:  Lung India       Date:  2011-07

8.  Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.

Authors:  Petros Isaakidis; Helen S Cox; Bhanumati Varghese; Chiara Montaldo; Esdras Da Silva; Homa Mansoor; Joanna Ladomirska; Giovanni Sotgiu; Giovanni B Migliori; Emanuele Pontali; Peter Saranchuk; Camilla Rodrigues; Tony Reid
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

9.  Prevalence of tuberculosis in Faridabad district, Haryana State, India.

Authors:  S K Sharma; Ashish Goel; S K Gupta; Krishna Mohan; V Sreenivas; S K Rai; U B Singh; L S Chauhan
Journal:  Indian J Med Res       Date:  2015-02       Impact factor: 2.375

10.  Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial.

Authors:  Soumya Swaminathan; Pradeep Aravindan Menon; Narendran Gopalan; Venkatesan Perumal; Ramesh Kumar Santhanakrishnan; Ranjani Ramachandran; Ponnuraja Chinnaiyan; Sheik Iliayas; Padmapriyadarsini Chandrasekaran; Pooranaganga Devi Navaneethapandian; Thiruvalluvan Elangovan; Mai Tuyet Pho; Fraser Wares; Narayanan Paranji Ramaiyengar
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.